Total Funding
78
38
Total FundingVenture - Series Unknown raised
Growth Score 78 in past quarter
-6 pts
Heat Score 38 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
48284
TearClear is a pharmaceutical company that specializes in providing a disruptive eye health technology.
- Anuj Chauhan: Chief Scientific Officer and Co-Founder
- Ken Banta: Co-Founder
About the Company
TearClear is a pharmaceutical company that specializes in providing a class platform of drugs that enables medication delivery to ultimately enhance patient safety and compliance by capturing preservatives before they reach the ocular surface.
Founded in 2015, TearClear is headquartered in California, United States.
